The protein expression levels of prosurvival/antiapoptotic molecules, p-AKT and Bcl-2, in the core region of the post-stroke brain were then seen to be higher in the PCE-treated group than in the vehicle-treated group after tMCAO (Figure 10). This evidence concerns the gene BCL2 and stroke disorder.